THURSDAY | SEPTEMBER 17, 2020
|
|
YOU HAVE 30 DAYS
FREE ACCESS
TO ASIPP VIRTUAL MEETING
|
|
THANK YOU FOR ATTENDING THE
ASIPP® VIRTUAL ANNUAL MEETING 2020!
The 30-day recorded version of the meeting is now available. You can log back in for 30 days at no extra charge with access to session videos and exhibit booths. You will have access to all presentation videos as well as the ability to peruse exhibit booths to look at any downloadable content or recorded product demos.
Please use your same link:
login, and password from the live meeting
to access the recorded version.
Following the 30-day post meeting window we will offer additional access through June 2021 for a nominal add-on fee.
|
|
Get up to date on the 2021
Coding Changes
|
|
Order Now - Recorded Virtual Review Courses
The following courses are offered:
- Documentation, Coding, Compliance, and Practice Management Review Course
- Controlled Substance Management Review Course
- Pain Medicine and Interventional Pain Management Comprehensive Review Course
|
|
ABIPP Recognizes Your Knowledge and Expertise
The American Board of Interventional Pain Physicians (ABIPP) has developed certification programs that recognize accepted levels of knowledge and expertise in the interventional pain management profession, with the goal of improved patient care. Hundreds of qualified physicians have made the commitment to become ABIPP certified.
ABIPP now offers the only competency
certification program for regenerative medicine.
For complete information about the examination requirements and to obtain an application packet, visit www.abipp.org or call 270-554-9412 x4217 or by email at summer@asipp.org.
|
|
TESTS OFFERED
ABIPP Part I - Theoretical written exam - TBD
ABIPP Part II - Oral and Hands-on practical exam - TBD
ABIPP Competency Exam - includes written, oral, and hands-on practical examinations TBD
Combined CSM/CCPM Exam for ABIPP Path – TBD
Competency Exam in Controlled Substance Management – TBD
Competency Exam in Coding, Compliance, and Practice Management - TBD
Regenerative Medicine Competency Exam - includes written, oral, and hands-on practical examinations – TBD
|
|
|
COVID-19 Risk 10-Fold Higher for Opioid Abusers
— Substance use disorders in general tied to higher coronavirus hospitalization rates
Substance use disorders (SUD), and particularly opioid use disorder (OUD), substantially increase the risk for COVID-19, according to an analysis of electronic health records (EHR).
Among over 73 million patients, the risk of COVID-19 was far higher among patients diagnosed with an SUD in the past year compared with the general population after adjusting for age, gender, race, and insurance type (adjusted odds ratio 8.7, 95% CI 8.4-9.0, P<10−30), reported Nora D. Volkow, MD, director of the National Institute on Drug Abuse (NIDA), and colleagues, in Molecular Psychiatry.
Patients with OUD had the highest risk (aOR 10.2, 95% CI 9.1-11.5, P<10−30), followed by patients with:
- Tobacco use disorder: aOR 8.2 (95% CI 7.9-8.5)
- Alcohol use disorder: aOR 7.8 (95% CI 7.0-8.5)
- Cocaine use disorder: aOR 6.5 (95% CI 5.2-8.1)
- Cannabis use disorder: aOR 5.3 (95% CI 4.4-6.4)
|
|
FDA Cracks Down on Websites Illegally Selling Opioids
Warning letters have been sent to 17 website operators for illegally selling unapproved and misbranded opioids online, according to the Food and Drug Administration (FDA).
The unapproved and misbranded opioids, which include tramadol and oxycodone, are being sold without a prescription and also lack adequate directions for use.
The warning letters were issued to the following 17 website operators:
Products sold on these websites have not been evaluated by the FDA and carry significant risks including addiction, abuse and misuse, and potentially life-threatening respiratory depression. Consumers who purchase prescription medications such as opioids from illegal online pharmacies may be putting their health at risk as the drugs may be counterfeit, contaminated, expired, or otherwise unsafe.
“Those who illegally sell opioids online put consumers at risk and undermine the significant strides we have made to combat the opioid crisis,” said Donald D. Ashley, director of the Office of Compliance in the FDA’s Center for Drug Evaluation and Research. “We remain committed to using all available tools to stop the illegal sale of opioids online to help protect consumers from these potentially dangerous products.”
For more information visit fda.gov.
|
|
Getting Real on COVID-19 Vaccine Timeline
— Research, production, and distribution obstacles seen likely to push delivery into 2021
As drug companies and the U.S. government scramble to develop a COVID-19 vaccine, experts on vaccine production and distribution questioned whether a vaccine could be in public hands by the end of the year and dismissed the idea that it could be ready before the Nov. 3 general election, which President Trump has openly championed.
Federal health officials, at the FDA and elsewhere, have all promised not to let politics dictate authorization or approval of a vaccine, but they've also been careful not to rule out a decision before the election.
|
|
ASIPP® Partners with Fedora Billing And Revenue Cycle Management Company
|
|
ASIPP is now able to offer unique benefits for revenue cycle management with billing, etc.
Fedora is a company known to many of our board members and others. ASIPP® has reached an agreement with Fedora to provide exclusive discounts on billing or revenue cycle management that will decrease practice costs and promote growth, or at least stop deterioration. It is not just a billing company; they streamline the billing and receivable process and constantly update payor regulations keeping your practice up to on date on a daily basis.
Some of the ASIPP® Billing Program highlights are below:
Up to 50% savings for ASIPP® members for their billing or revenue cycle management for their offices and surgery centers:
- Expertise in interventional pain management billing for all types of services
- 99% Clearing House Rate
- 95% First-Time Claim Passage
- 23.4 Average Days in A/R
- Eligibility and Benefits Verification
- Pre-Certification/Prior Authorization
- Denials and A/R Management
|
|
Join The Group Purchasing
Organization Today
|
|
ASIPP® has formed a partnership with Henry Schein and PedsPal, a national GPO that has a successful history of negotiating better prices on medical supplies and creating value added services for the independent physician. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today. While the cost of contrast media has skyrocketed due to the single dose vial issue, because we have partnered with Henry Schein, this could enable you to purchase Omnipaque 240mg/50mL for slightly above $4.50.
Click on “view our discounted supplier prices” (Username: ASIPPmember and Password: Save) or click on the words "join for free now" and begin saving today!
|
|
Essentials of Regenerative Medicine in Interventional
Pain Management
|
|
|
|
Essentials of Regenerative Medicine in Interventional Pain Management is a book to bring concise, collective, and comprehensive information to interventional pain physicians practicing regenerative medicine in managing chronic pain. Regenerative medicine is an integral part of interventional pain management within the definitions of interventional pain management and interventional techniques.
Each chapter contains an introduction of the subject, historical context,pathophysiology, applicability of regenerative medicine with its evidence base, indications, anatomy, technical aspects, complications, and precautions for each topic when available and applicable. This comprehensive book consists of 35 chapters, more than 350 figures, and 50 tables.
|
|
| ORDER | Essentials of Regenerative Medicine in IPM
|
|
Control Your Waiting Room TV
Customized waiting room TV exclusively for ASIPP® members. Create your own ad-free television broadcasts using our videos, custom informational slides and your own YouTube videos. Even add local weather reports, news and live messages.
|
|
|
In addition, PainExam has now collaborated with ASIPP and offer 2 new programs:
|
|
|
|
|
2020 12th Annual Scientific
Meeting
|
|
|
|
|
|
|
|
|
|
